English
Insider transactions
EDGARC4 THERAPEUTICS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-17.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 2 transactions, 55,173 shares
- Sum of shares × price per share: 144,686.5895
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 53
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 Filed 2026-11-13 | Adams Kendra Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 45,173 | 2.7115 | 122,486.5895Derived: shares × price per share. Exact value 122486.5895. | 337,150 | Direct (D) | Yes | F1, F2
| Open filing 0001470831-26-001003 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | Anderson Kenneth Carl Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,662 | 3.14 | 11,498.68Derived: shares × price per share. Exact value 11498.68. | 75,612 | Direct (D) | No | F1, F2
| Open filing 0001470831-26-000925 Read from the filing’s XML Dispute this row |
| 2026-10-01 Filed 2026-10-02 | GROGAN DONNA ROY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,618 | 3.14 | 14,500.52Derived: shares × price per share. Exact value 14500.52. | 79,471 | Direct (D) | No | F1, F2
| Open filing 0001470831-26-000924 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-21 | Adams Kendra Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 6,250 | 0 | — | 385,098 | Direct (D) | No | F1
| Open filing 0001470831-26-000895 Read from the filing’s XML Dispute this row |
| 2026-09-18 Filed 2026-09-21 | Adams Kendra Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 2,775 | 3.39 | 9,407.25Derived: shares × price per share. Exact value 9407.25. | 382,323 | Direct (D) | No | F2
| Open filing 0001470831-26-000895 Read from the filing’s XML Dispute this row |
| 2026-07-10 Filed 2026-07-13 | REYNO LEONARD Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 15,325 | 0 | — | 379,803 | Direct (D) | No | F1
| Open filing 0001470831-26-000705 Read from the filing’s XML Dispute this row |
| 2026-07-10 Filed 2026-07-13 | REYNO LEONARD Officer: Chief Medical Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 7,397 | 4.06 | 30,031.82Derived: shares × price per share. Exact value 30031.82. | 372,406 | Direct (D) | No | F2
| Open filing 0001470831-26-000705 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | GROGAN DONNA ROY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 3,341 | 4.34 | 14,499.94Derived: shares × price per share. Exact value 14499.94. | 74,853 | Direct (D) | No | F1, F2
| Open filing 0001470831-26-000689 Read from the filing’s XML Dispute this row |
| 2026-07-01 Filed 2026-07-02 | Anderson Kenneth Carl Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,650 | 4.34 | 11,501Derived: shares × price per share. Exact value 11501.00. | 71,950 | Direct (D) | No | F1, F2
| Open filing 0001470831-26-000688 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Koppikar Utpal Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000667 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | GROGAN DONNA ROY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000657 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Fawell Stephen Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000659 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Anderson Kenneth Carl Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000665 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Bessen Laura Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000661 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Hughes Owen Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000673 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Hoerter Steven L. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000670 Read from the filing’s XML Dispute this row |
| 2026-06-24 Filed 2026-06-26 | Cooper Ronald Harold Wilfred Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 62,000 | 0 | — | 62,000 | Direct (D) | No | F1
| Open filing 0001470831-26-000663 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-04 | Anderson Kenneth Carl Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,070 | 2.11 | 2,257.7Derived: shares × price per share. Exact value 2257.70. | 69,300 | Direct (D) | No | F1
| Open filing 0001470831-26-000504 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-04 | Anderson Kenneth Carl Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,070 | 0 | — | 0 | Direct (D) | No | F1, F7
| Open filing 0001470831-26-000504 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-03 | Anderson Kenneth Carl Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,259 | 2.70 | 11,499.3Derived: shares × price per share. Exact value 11499.30. | 68,230 | Direct (D) | No | F1, F2
| Open filing 0001470831-26-000346 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-03 | GROGAN DONNA ROY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 5,370 | 2.70 | 14,499Derived: shares × price per share. Exact value 14499.00. | 71,512 | Direct (D) | No | F1, F2
| Open filing 0001470831-26-000345 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Hirsch Andrew Director · Officer: President CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,400 | 0 | — | 1,083,991 | Direct (D) | No | F2
| Open filing 0001470831-26-000177 Read from the filing’s XML Dispute this row |
| 2026-02-15 Filed 2026-02-18 | Hirsch Andrew Director · Officer: President CEO | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 9,057 | 1.89 | 17,117.73Derived: shares × price per share. Exact value 17117.73. | 1,074,934 | Direct (D) | No | F3
| Open filing 0001470831-26-000177 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Adams Kendra Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 30,950 | 0 | — | 400,479 | Direct (D) | No | F2
| Open filing 0001470831-26-000175 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Adams Kendra Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 15,381 | 1.89 | 29,070.09Derived: shares × price per share. Exact value 29070.09. | 385,098 | Direct (D) | No | F3
| Open filing 0001470831-26-000175 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Boyle Scott N Officer: Chief Business Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,950 | 0 | — | 306,070 | Direct (D) | No | F2
| Open filing 0001470831-26-000180 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Boyle Scott N Officer: Chief Business Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 7,269 | 1.89 | 13,738.41Derived: shares × price per share. Exact value 13738.41. | 298,801 | Direct (D) | No | F2
| Open filing 0001470831-26-000180 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Mahaney Paige Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 7,050 | 0 | — | 339,356 | Direct (D) | No | F2
| Open filing 0001470831-26-000179 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Mahaney Paige Officer: Chief Scientific Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 2,446 | 1.89 | 4,622.94Derived: shares × price per share. Exact value 4622.94. | 336,910 | Direct (D) | No | F3
| Open filing 0001470831-26-000179 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Mossler Mark Officer: Chief Accounting Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 9,420 | 0 | — | 75,184 | Direct (D) | No | F2
| Open filing 0001470831-26-000174 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Mossler Mark Officer: Chief Accounting Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 3,268 | 1.89 | 6,176.52Derived: shares × price per share. Exact value 6176.52. | 71,916 | Direct (D) | No | F3
| Open filing 0001470831-26-000174 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Schick Kelly Officer: Chief People Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 20,950 | 0 | — | 307,150 | Direct (D) | No | F2
| Open filing 0001470831-26-000178 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Schick Kelly Officer: Chief People Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 7,269 | 1.89 | 13,738.41Derived: shares × price per share. Exact value 13738.41. | 299,881 | Direct (D) | No | F3
| Open filing 0001470831-26-000178 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | REYNO LEONARD Officer: Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 30,950 | 0 | — | 396,382 | Direct (D) | No | F2
| Open filing 0001470831-26-000176 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | REYNO LEONARD Officer: Chief Medical Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 16,579 | 1.89 | 31,334.31Derived: shares × price per share. Exact value 31334.31. | 379,803 | Direct (D) | No | F3
| Open filing 0001470831-26-000176 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Hirsch Andrew Director · Officer: President CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 81,725 | 0 | — | 1,123,145 | Direct (D) | No | F2
| Open filing 0001470831-26-000177 Read from the filing’s XML Dispute this row |
| 2026-02-14 Filed 2026-02-18 | Hirsch Andrew Director · Officer: President CEO | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 39,154 | 1.89 | 74,001.06Derived: shares × price per share. Exact value 74001.06. | 1,083,991 | Direct (D) | No | F3
| Open filing 0001470831-26-000177 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Adams Kendra Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 240,000 | 0 | — | 402,342 | Direct (D) | No | F1
| Open filing 0001470831-26-000175 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Adams Kendra Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,750 | 0 | — | 402,342 | Direct (D) | No | F2
| Open filing 0001470831-26-000175 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Adams Kendra Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,863 | 1.89 | 3,521.07Derived: shares × price per share. Exact value 3521.07. | 400,479 | Direct (D) | No | F3
| Open filing 0001470831-26-000175 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Boyle Scott N Officer: Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 200,000 | 0 | — | 307,805 | Direct (D) | No | F1
| Open filing 0001470831-26-000180 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Boyle Scott N Officer: Chief Business Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 5,000 | 0 | — | 307,805 | Direct (D) | No | F2
| Open filing 0001470831-26-000180 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Boyle Scott N Officer: Chief Business Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,735 | 1.89 | 3,279.15Derived: shares × price per share. Exact value 3279.15. | 306,070 | Direct (D) | No | F3
| Open filing 0001470831-26-000180 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Mahaney Paige Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 240,000 | 0 | — | 339,356 | Direct (D) | No | F1
| Open filing 0001470831-26-000179 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Mossler Mark Officer: Chief Accounting Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 56,980 | 0 | — | 75,184 | Direct (D) | No | F1
| Open filing 0001470831-26-000174 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Schick Kelly Officer: Chief People Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 200,000 | 0 | — | 308,885 | Direct (D) | No | F1
| Open filing 0001470831-26-000178 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Schick Kelly Officer: Chief People Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 5,000 | 0 | — | 308,885 | Direct (D) | No | F2
| Open filing 0001470831-26-000178 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Schick Kelly Officer: Chief People Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 1,735 | 1.89 | 3,279.15Derived: shares × price per share. Exact value 3279.15. | 307,150 | Direct (D) | No | F3
| Open filing 0001470831-26-000178 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | REYNO LEONARD Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 240,000 | 0 | — | 396,382 | Direct (D) | No | F1
| Open filing 0001470831-26-000176 Read from the filing’s XML Dispute this row |
| 2026-02-13 Filed 2026-02-18 | Hirsch Andrew Director · Officer: President CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 700,000 | 0 | — | 1,123,145 | Direct (D) | No | F1
| Open filing 0001470831-26-000177 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-16. Prior quarter ending 2026-06-30: 9,164 filings read.
Showing 1–50 of 161
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Squadron Capital Management LLC | 9,318,683 SH | 31,031,214 dollars | Higher by 2,118,683 Prior quarter: 7,200,000 | Open filing 0002050709-26-000036 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 8,872,634 SH | 29,545,871 dollars | Higher by 5,296 Prior quarter: 8,867,338 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| RA CAPITAL MANAGEMENT, L.P. | 8,194,779 SH | 27,288,614 dollars | Higher by 194,779 Prior quarter: 8,000,000 | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 8,179,926 SH | 27,239,155 dollars | Higher by 283,208 Prior quarter: 7,896,718 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Lynx1 Capital Management LP Partly reported under another manager | 7,530,915 SH | 25,077,947 dollars | Higher by 204,224 Prior quarter: 7,326,691 | Open filing 0001910456-26-000007 Filed 2026-11-16 Dispute this row |
| Bain Capital Life Sciences Investors, LLC | 7,171,910 SH | 23,882,460 dollars | Unchanged Prior quarter: 7,171,910 | Open filing 0001193125-26-462089 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 5,006,879 SH | 16,672,907 dollars | Higher by 819,299 Prior quarter: 4,187,580 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 4,696,984 SH | 14,701,559 dollars | Lower by 50,440 Prior quarter: 4,747,424 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 4,683,379 SH | 15,595,652 dollars | Higher by 1,152,388 Prior quarter: 3,530,991 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,581,502 SH | 15,256,402 dollars | Higher by 163,771 Prior quarter: 4,417,731 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| WASATCH ADVISORS LP Partly reported under another manager | 4,160,048 SH | 13,852,960 dollars | Higher by 637,404 Prior quarter: 3,522,644 | Open filing 0000814133-26-000137 Filed 2026-10-13 Dispute this row |
| Boxer Capital Management, LLC | 4,150,000 SH | 13,819,500 dollars | Not in the prior quarter’s filings read | Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 3,746,738 SH | 12,476,638 dollars | Higher by 277,031 Prior quarter: 3,469,707 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,454,647 SH | 11,503,975 dollars | Higher by 422,587 Prior quarter: 3,032,060 | Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row |
| Soleus Capital Management, L.P. | 3,357,981 SH | 11,182,077 dollars | Lower by 20,000 Prior quarter: 3,377,981 | Open filing 0001802630-26-000008 Filed 2026-11-16 Dispute this row |
| STEMPOINT CAPITAL LP | 3,293,376 SH | 10,966,942 dollars | Higher by 2,769,728 Prior quarter: 523,648 | Open filing 0001420506-26-002774 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 2,890,772 SH | 9,626,270 dollars | Higher by 234,413 Prior quarter: 2,656,359 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Candriam S.C.A. | 2,760,346 SH | 9,225,536 dollars | Higher by 963,409 Prior quarter: 1,796,937 | Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 2,699,545 SH | 8,991,069 dollars | Higher by 177,382 Prior quarter: 2,522,163 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Qube Research Technologies Ltd | 2,397,086 SH | 7,982,296 dollars | Higher by 2,026,532 Prior quarter: 370,554 | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| ADAR1 Capital Management, LLC | 2,232,857 SH | 7,435,414 dollars | Higher by 1,940,900 Prior quarter: 291,957 | Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 2,218,580 SH | 7,387,871 dollars | Higher by 102,959 Prior quarter: 2,115,621 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 2,162,093 SH | 7,199,770 dollars | Higher by 421,104 Prior quarter: 1,740,989 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| Ikarian Capital, LLC | 1,933,000 SH | 6,436,890 dollars | Lower by 500,000 Prior quarter: 2,433,000 | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager | 1,787,391 SH | 5,950 dollars | Lower by 18,808 Prior quarter: 1,806,199 | Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 1,384,966 SH | 4,609,336 dollars | Higher by 196,459 Prior quarter: 1,188,507 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| CONGRESS ASSET MANAGEMENT CO | 1,256,692 SH | 4,184,784 dollars | Higher by 253,255 Prior quarter: 1,003,437 | Open filing 0000897378-26-000015 Filed 2026-10-06 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,234,707 SH | 4,111,574 dollars | Higher by 453,647 Prior quarter: 781,060 | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 1,209,376 SH | 4,027,222 dollars | Higher by 19,548 Prior quarter: 1,189,828 | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| FMR LLC Partly reported under another manager | 1,175,723 SH | 3,915,157 dollars | Higher by 281,669 Prior quarter: 894,054 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 1,157,394 SH | 3,854,121 dollars | Lower by 3,153 Prior quarter: 1,160,547 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,094,194 SH | 3,643,666 dollars | Higher by 414,100 Prior quarter: 680,094 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| Atom Investors LP | 911,528 SH | 3,035,388 dollars | Higher by 547,177 Prior quarter: 364,351 | Open filing 0001214659-26-014237 Filed 2026-11-16 Dispute this row |
| HighVista Strategies LLC | 873,277 SH | 2,908,012 dollars | Lower by 474,859 Prior quarter: 1,348,136 | Open filing 0001172661-26-004983 Filed 2026-11-13 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 855,805 SH | 2,849,832 dollars | Higher by 628,802 Prior quarter: 227,003 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC | 767,992 SH | 2,557,413 dollars | Not in the prior quarter’s filings read | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 737,000 SH | 2,454,210 dollars | Higher by 477,700 Prior quarter: 259,300 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 721,744 SH | 2,403,408 dollars | Higher by 112,598 Prior quarter: 609,146 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| PANAGORA ASSET MANAGEMENT INC | 690,687 SH | 2,299,988 dollars | Higher by 425,740 Prior quarter: 264,947 | Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 591,832 SH | 1,970,800 dollars | Higher by 107,822 Prior quarter: 484,010 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| BOOTHBAY FUND MANAGEMENT, LLC | 585,009 SH | 1,948,080 dollars | Lower by 151,322 Prior quarter: 736,331 | Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row |
| PLATINUM INVESTMENT MANAGEMENT LTD | 577,534 SH | 1,923,188 dollars | Higher by 192,768 Prior quarter: 384,766 | Open filing 0001256071-26-000016 Filed 2026-11-16 Dispute this row |
| Connor, Clark Lunn Investment Management Ltd. | 546,352 SH | 1,819,352 dollars | Higher by 245,618 Prior quarter: 300,734 | Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row |
| Rockefeller Capital Management L.P. Partly reported under another manager | 517,591 SH | 1,723,578 dollars | Higher by 21,774 Prior quarter: 495,817 | Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 516,551 SH | 1,720,115 dollars | Higher by 345,717 Prior quarter: 170,834 | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| Ikarian Capital, LLC Option: Call | 500,000 SH | 1,665,000 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 494,965 SH | 1,648,233 dollars | Lower by 1,237,245 Prior quarter: 1,732,210 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| SCHRODER INVESTMENT MANAGEMENT GROUP Partly reported under another manager | 451,930 SH | 1,414,541 dollars | Not in the prior quarter’s filings read | Open filing 0001140361-26-044129 Filed 2026-11-16 Dispute this row |
| Squadron Capital Management LLC Option: Call | 400,000 SH | 1,332,000 dollars | Unchanged Prior quarter: 400,000 | Open filing 0002050709-26-000036 Filed 2026-11-16 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 396,270 SH | 1,319,579 dollars | Lower by 56,431 Prior quarter: 452,701 | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Patient Square Capital LP 1,608,815 SH
- Sixth Street Partners Management Company, L.P. 781,060 SH
- ExodusPoint Capital Management, LP 580,195 SH
- ADAGE CAPITAL PARTNERS GP, L.L.C. 325,000 SH
- Headlands Technologies LLC 153,972 SH
- Virtu Financial LLC 98,094 SH
- Aster Capital Management (DIFC) Ltd 77,734 SH
- Jain Global LLC 57,562 SH
- Thrivent Financial for Lutherans 52,763 SH
- Quadrature Capital Ltd 36,726 SH
- Dynamic Technology Lab Private Ltd 32,828 SH
- JACOBS LEVY EQUITY MANAGEMENT, INC 25,111 SH
- NEW YORK STATE COMMON RETIREMENT FUND 24,100 SH
- StoneX Group Inc. 22,420 SH
- Scientech Research LLC 21,260 SH
- Quantbot Technologies LP 20,827 SH
- INTECH INVESTMENT MANAGEMENT LLC 19,602 SH
- State of Wyoming 16,093 SH
- ALGERT GLOBAL LLC 16,040 SH
- EWA, LLC 14,129 SH
- HSBC HOLDINGS PLC 13,629 SH
- Northern Lights Advisors, Inc. 12,930 SH
- RAYMOND JAMES FINANCIAL INC 11,860 SH
- WINTON GROUP Ltd 11,100 SH
- AXQ CAPITAL, LP 10,745 SH
- PFG Investments, LLC 10,000 SH
- SUMMIT SECURITIES GROUP LLC 829 SH
- Integrated Wealth Concepts LLC 662 SH
- Optiver Holding B.V. 358 SH
- Walleye Capital LLC 300 SH
- HUNTINGTON NATIONAL BANK 107 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Squadron Master Fund LP Common Stock, $0.0001 par value per share | 7.9 | 9,718,683.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0002050709-26-000030 Dispute this row |
| Squadron Capital Management LLC Common Stock, $0.0001 par value per share | 7.9 | 9,718,683.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0002050709-26-000030 Dispute this row |
| Matthew Sesterhenn Common Stock, $0.0001 par value per share | 7.9 | 9,718,683.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0002050709-26-000030 Dispute this row |
| William Blank Common Stock, $0.0001 par value per share | 7.9 | 9,718,683.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0002050709-26-000030 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.0001 par value per share | 9.9 | 13,654,272.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000277 Dispute this row |
| Peter Kolchinsky Common Stock, $0.0001 par value per share | 9.9 | 13,654,272.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000277 Dispute this row |
| Rajeev Shah Common Stock, $0.0001 par value per share | 9.9 | 13,654,272.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000277 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.0001 par value per share | 9.9 | 13,654,272.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0001346824-26-000277 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.0001 par value per share | 9.9 | 11,383,696.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000920 Dispute this row |
| Peter Kolchinsky Common Stock, $0.0001 par value per share | 9.9 | 11,383,696.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000920 Dispute this row |
| Rajeev Shah Common Stock, $0.0001 par value per share | 9.9 | 11,383,696.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000920 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.0001 par value per share | 9.9 | 11,383,696.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001231919-26-000920 Dispute this row |
| Lynx1 Capital Management LP Common Stock, $0.0001 par value per share | 9.99 | 15,423,691.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0000902664-26-003524 Dispute this row |
| Weston Nichols Common Stock, $0.0001 par value per share | 9.99 | 15,423,691.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0000902664-26-003524 Dispute this row |
| Squadron Master Fund LP Common Stock, $0.0001 par value per share | 6.9 | 7,600,000.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0002050709-26-000022 Dispute this row |
| Squadron Capital Management LLC Common Stock, $0.0001 par value per share | 6.9 | 7,600,000.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0002050709-26-000022 Dispute this row |
| Matthew Sesterhenn Common Stock, $0.0001 par value per share | 6.9 | 7,600,000.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0002050709-26-000022 Dispute this row |
| William Blank Common Stock, $0.0001 par value per share | 6.9 | 7,600,000.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0002050709-26-000022 Dispute this row |
| Morgan Stanley Common Stock | 8.0 | 8,862,002 | 06/30/2026 Filed 2026-08-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0000895421-26-000231 Dispute this row |
| Morgan Stanley Capital Services LLC Common Stock | 7.9 | 8,718,000 | 06/30/2026 Filed 2026-08-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0000895421-26-000231 Dispute this row |
| Morgan Stanley Co. LLC Common Stock | 0.1 | 134,047 | 06/30/2026 Filed 2026-08-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0000895421-26-000231 Dispute this row |
| BlackRock, Inc. Common Stock | 6.9 | 7,678,906 | 06/30/2026 Filed 2026-07-27 | SCHEDULE 13G | Open filing 0002012383-26-002217 Dispute this row |
| Squadron Master Fund LP Common Stock, $0.0001 par value per share | 5.0 | 5,550,000.00 | 05/12/2026 Filed 2026-05-19 | SCHEDULE 13G | Open filing 0002050709-26-000018 Dispute this row |
| Squadron Capital Management LLC Common Stock, $0.0001 par value per share | 5.0 | 5,550,000.00 | 05/12/2026 Filed 2026-05-19 | SCHEDULE 13G | Open filing 0002050709-26-000018 Dispute this row |
| Matthew Sesterhenn Common Stock, $0.0001 par value per share | 5.0 | 5,550,000.00 | 05/12/2026 Filed 2026-05-19 | SCHEDULE 13G | Open filing 0002050709-26-000018 Dispute this row |
| William Blank Common Stock, $0.0001 par value per share | 5.0 | 5,550,000.00 | 05/12/2026 Filed 2026-05-19 | SCHEDULE 13G | Open filing 0002050709-26-000018 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 0.2 | 169,096.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003479 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 0.2 | 169,096.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003479 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 0.2 | 169,096.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-003479 Dispute this row |
| Sirenia Capital Management LP Common Stock, par value $0.0001 per share | 9.9 | 23,505,000.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0000919574-26-003216 Dispute this row |
| Alex Silverstein Common Stock, par value $0.0001 per share | 9.9 | 23,505,000.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G | Open filing 0000919574-26-003216 Dispute this row |
| Wasatch Advisors LP COM STK | 4.7 | 4,581,761.00 | 03/31/2026 Filed 2026-04-22 | SCHEDULE 13G/AAmendment 6 | Open filing 0000814133-26-000050 Dispute this row |
| OrbiMed Advisors LLC Common Stock, par value $0.0001 per share | 0.5 | 521,368.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0000947871-26-000188 Dispute this row |
| OrbiMed Capital LLC Common Stock, par value $0.0001 per share | 1.0 | 883,534.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0000947871-26-000188 Dispute this row |
| Lynx1 Capital Management LP Common Stock, $0.0001 par value per share | 7.3 | 7,098,133.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0000902664-26-001046 Dispute this row |
| Weston Nichols Common Stock, $0.0001 par value per share | 7.3 | 7,098,133.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 3 | Open filing 0000902664-26-001046 Dispute this row |
| Soleus Private Equity Fund III, L.P. Common Stock, par value $0.0001 per share | 5.9 | 6,072,822.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus Private Equity GP III, LLC Common Stock, par value $0.0001 per share | 5.9 | 6,072,822.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus PE GP III, LLC Common Stock, par value $0.0001 per share | 5.9 | 6,072,822.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus Capital Master Fund, L.P. Common Stock, par value $0.0001 per share | 9.99 | 10,361,860.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus Capital, LLC Common Stock, par value $0.0001 per share | 9.99 | 10,361,860.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus Capital Group, LLC Common Stock, par value $0.0001 per share | 9.99 | 10,361,860.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus Capital Management, L.P. Common Stock, par value $0.0001 per share | 9.99 | 10,334,114.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Soleus GP, LLC Common Stock, par value $0.0001 per share | 9.99 | 10,334,114.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Guy Levy Common Stock, par value $0.0001 per share | 9.99 | 10,334,114.00 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 2 | Open filing 0001213900-26-015656 Dispute this row |
| Morgan Stanley Common Stock | 9.3 | 8,974,191 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 2 | Open filing 0000895421-26-000033 Dispute this row |
| Morgan Stanley Co. LLC Common Stock | 9.2 | 8,897,942 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 2 | Open filing 0000895421-26-000033 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.0001 par value per share | 9.9 | 9,441,256.00 | 10/17/2025 Filed 2025-10-24 | SCHEDULE 13G | Open filing 0001346824-25-000025 Dispute this row |
| Peter Kolchinsky Common Stock, $0.0001 par value per share | 9.9 | 9,441,256.00 | 10/17/2025 Filed 2025-10-24 | SCHEDULE 13G | Open filing 0001346824-25-000025 Dispute this row |
| Rajeev Shah Common Stock, $0.0001 par value per share | 9.9 | 9,441,256.00 | 10/17/2025 Filed 2025-10-24 | SCHEDULE 13G | Open filing 0001346824-25-000025 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,212,651 filings read, dated 2004-06-14 to 2026-11-16: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 130,393 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 260,165 |
Filings made before the SEC required XML are listed, not extracted.